Connect to other sites within the UBM Medica Network
Four questions for you to answer, four facts you need to know.
Abridged Diabetes Guidelines for Primary Care: 6 Noteworthy Changes
The ADA provides an abridged version for PCPs of its annual Standards of Medical Care. Our slides summarize 6 updates important to primary care.
I'm a DO--And My Day Job Is Teaching
“Doctor” comes from the Latin docēre, “to teach.”
Metformin Trims Colorectal Cancer Risk in Diabetes
The drug appeared to reduce the risk in the first study to assess its effects on younger patients with diabetes in the United States.
Have You Heard This (Week's) News?
Microbes in the gut affect metabolic pathways involved in the pathogenesis of obesity, insulin resistance, and diabetes. Antibiotics can alter gut microbiota.
Aflibercept (Eylea, Regeneron Pharmaceuticals), a second ophthalmic vascular endothelial growth factor inhibitor, has received FDA approval for the treatment of diabetic retinopathy in patients with diabetic macular edema.
Poor GLP-1 Response Seen Before Type 2 Diabetes Develops
A Danish study found reduced endogenous levels of glucagon-like peptide-1 in persons with prediabetes. Perhaps the incretin system defect comes first.
Comorbid Curiosity: Which One Doesn't Pertain?
Conditions associated with long-term diabetes affect myriad organs and systems. Which one of these comorbidities is not associated with the disease?
Five Top Papers From 2014 That Will Impact Your Practice
New drugs that treat stubborn illness seen often in primary care lead this group of Top 5 Papers for 2014. Type 2 diabetes, cryptogenic stroke, and hep-C are key targets.
By clicking Accept, you agree to become a member of the UBM Medica Community.